Lotus Pharmaceuticals, Inc. Share Price Other OTC
Equities
LTUS
US5457152032
Pharmaceuticals
Sales 2009 | 57.82M 4.62B | Sales 2010 | 72.7M 5.81B | Capitalization | 69.15M 5.52B |
---|---|---|---|---|---|
Net income 2009 | 16M 1.28B | Net income 2010 | 14M 1.12B | EV / Sales 2009 | 1.02 x |
Net Debt 2009 | 5.29 422.8 | Net Debt 2010 | 4.65 371.12 | EV / Sales 2010 | 0.95 x |
P/E ratio 2009 |
3.88
x | P/E ratio 2010 |
4.84
x | Employees | - |
Yield 2009 * |
-
| Yield 2010 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Georgene Rivers
CEO | Chief Executive Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Georgene Rivers
CEO | Chief Executive Officer | - | - |
1st Jan change | Capi. | |
---|---|---|
+19.62% | 43.27B | |
+24.52% | 22.92B | |
+20.29% | 15.43B | |
+7.48% | 12.95B | |
+42.51% | 11.83B | |
-8.84% | 6.91B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.13% | 5.55B |